US Rep. Gaetz’s Diagnosis of What’s Driving Insulin Costs Misses the Root Cause
Kaiser Health News
APRIL 22, 2022
However, the pharmaceutical industry disagrees with this assessment. PhRMA, the trade industry group representing pharmaceutical companies, told KHN that while it acknowledges drug manufacturers are responsible for raising the list price of insulin, the manufacturers aren’t reaping the benefits of the price increase.
118 
Let's personalize your content